Topiramate
Active substance: topiramate
CAPSULE, EXTENDED RELEASE · TOPIRAMATE 200 mg/1
United StatesActive
Marketing holder: Zydus Lifesciences Limited
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 3
- TOPIRAMATE · 200 mg/1
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| RU 42 |
|
| EU 1 |
|
Control by country
- Russiaprescription only
Source: GRLS (Russian state register) · record 01a120c3-3399-7c7e-b68d-1cce0c803e0b,01a120c3-3999-71c3-93fb-96ed85fcbe48,01a120c3-5461-7986-87b3-714a7c8aa3c6,01a120c3-56b6-7ec3-9df0-e7f457144fe7,01a120c3-5a00-78ad-ad8b-cf849caec350;count=35 · valid from 2026-10-09 · verified 2026-10-09
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-2995-7730-9f07-4cf4711ec479,01a1208c-2996-7425-ba54-a50783427a8e,01a1208c-2d2e-7428-a56d-a8acc59a3203,01a1208c-310e-7d0f-895c-12b925edb4b3,01a1208c-3fea-7421-87c7-5df8db9190c6;count=297 · valid from 2026-10-09 · verified 2026-10-09
- Registration number
- 70771-1660
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
- product · openFDA NDC · 70771-1660 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 70771-1660 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 70771-1660 · Verified 2026-10-09 · open in source